Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

COCH Envoy Medical, Inc. Class A Common Stock
$0.65 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy COCH stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 50.3M
Enterprise value 31.4M
Trailing PE -0.52943089144017
Forward PE -2.959091
PEG Ratio 0.0067767154104341
Enterprise to EBITDA -1.357
Enterprise to revenue 151.617
Price to book MRQ 13.5625
Price to sales TTM 242.77141

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 207.0K
EBITDA -23128000
Diluted EPS TTM -0.76
Total Cash (MRQ) 19.7M
Current ratio (MRQ) 1.735
Operating Cash Flow (TTM) -21533000

COCH trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent COCH News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.